VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PROF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PROFProfound Medical Corp.
$7.44$225M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPROFQuarterly Financials

Profound Medical Corp. (PROF) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Profound Medical Corp. (PROF) quarterly income statement — complete revenue, gross profit & net income history

PROF Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue5.26M5.98M5.29M2.21M2.62M5.33M3.83M2.23M1.44M2.66M1.73M1.6M1.86M1.7M2.81M2.01M1.71M1.26M3.21M2.6M
Revenue Growth %100.8%12.21%38.1%-0.96%82.14%100.11%121.63%39.36%-22.64%56.4%-38.52%-20.21%9.08%34.86%-12.55%-22.92%90.83%-65.56%43.6%153.87%
Cost of Goods Sold1.48M1.99M1.36M593K768K1.7M1.39M811.83K573K1.35M668K552K665.05K945.06K1.31M1.08M1.16M633.53K1.96M1.4M
COGS % of Revenue28.2%33.23%25.68%26.82%29.3%31.88%36.23%36.36%39.82%50.77%38.66%34.46%35.75%55.53%46.44%53.78%68.04%50.2%61.1%53.71%
Gross Profit3.78M3.99M3.93M1.62M1.85M3.63M2.44M1.42M866K1.31M1.06M1.05M1.2M756.86K1.51M928.02K545.09K628.47K1.25M1.21M
Gross Margin %71.8%66.77%74.32%73.18%70.7%68.12%63.77%63.64%60.18%49.23%61.34%65.54%64.25%44.47%53.56%46.22%31.96%49.8%38.9%46.29%
Gross Profit Growth %103.94%9.98%60.96%13.89%113.97%176.92%130.4%35.31%-27.54%73.14%-29.59%13.14%119.25%20.43%20.41%-23.03%72.11%-56.79%-15.12%189.83%
Operating Expenses11.69M11.36M12.84M15.42M13.02M86.1M-9.71M9.26M8.74M65.55M7.62M-5.39M8.04M75.81M-9.87M8.64M-8.57M64.93M-8.39M7.54M
OpEx % of Revenue222.09%190.06%242.84%697.6%496.72%1616.44%-253.6%414.82%607.57%2462.62%440.97%-336.2%432.37%4454.18%-351.06%430.32%-502.64%5145.39%-260.94%289.3%
Selling, General & Admin6.5M7.09M7.43M9.33M8.21M23.77M8.98M5.06M4.8M16.89M4.21M4.33M4.19M5.1M6.34M4.98M5.69M6.99M5.75M4.15M
SG&A % of Revenue123.5%118.59%140.4%421.8%313.28%446.32%234.46%226.51%333.43%634.49%243.34%270.35%225.27%299.76%225.6%248.2%333.43%553.71%178.95%159.15%
Research & Development5.19M4.27M5.42M6.1M4.81M6.74M5.62M4.2M3.94M5.32M3.42M3.15M3.85M4.73M6.54M3.66M3.98M6.85M5.14M3.39M
R&D % of Revenue98.59%71.47%102.44%275.8%183.44%126.45%146.68%188.31%274.15%199.8%197.63%196.94%207.1%278.12%232.58%182.12%233.14%542.79%159.8%130.15%
Other Operating Expenses000001000K-1000K001000K0-1000K01000K-1000K0-1000K1000K-1000K0
Operating Income-7.91M-7.37M-8.91M-13.81M-11.17M-82.47M12.15M-7.84M-7.88M-64.24M-6.56M6.44M-6.85M-75.05M11.37M-7.71M9.12M-64.31M9.64M-6.33M
Operating Margin %-150.29%-123.29%-168.52%-624.42%-426.02%-1548.31%317.37%-351.19%-547.39%-2413.39%-379.63%401.75%-368.12%-4409.71%404.62%-384.1%534.6%-5095.59%299.84%-243.01%
Operating Income Growth %29.16%91.06%-173.33%-76.09%-41.75%-28.38%285.28%-221.82%-15.03%14.4%-157.68%183.46%-175.11%-16.71%18.01%-21.83%10.37%-54%287.41%-60.66%
EBITDA-7.81M-7.26M-8.77M-13.66M-11M-81.94M12.38M-7.61M-7.63M-63.92M-6.27M6.71M-6.62M-74.84M11.81M-7.22M9.64M-64.07M10.15M-5.86M
EBITDA Margin %-148.42%-121.47%-165.74%-618.05%-419.8%-1538.22%323.34%-340.71%-530.02%-2401.2%-363.02%419.04%-355.81%-4397.14%420.15%-359.56%565.32%-5076.86%315.73%-225.09%
EBITDA Growth %29.01%91.14%-170.79%-79.65%-44.26%-28.19%297.4%-213.31%-15.24%14.59%-153.12%192.99%-168.65%-16.8%16.38%-23.13%10.91%-54.01%313.98%-64.41%
D&A (Non-Cash Add-back)98.61K109K147K141K163K537.7K228.54K233.95K250K324.62K287K277K229.02K213.92K436.45K492.76K523.84K236.47K510.52K467K
EBIT-7.91M-7.37M-8.91M-13.81M-11.17M-12.59M-12.15M-6.9M-7.88M-11.68M-6.56M-6.44M-6.81M-8.53M-11.37M-5.85M-9.12M-12.3M-9.64M-6.9M
Net Interest Income371.78K0000-2.06M-199K934K1.32M-323.71K1.01M125.64K-35K396.6K3.27M227K62K88.7K023K
Interest Income371.78K0000-1.64M0786.75K850.96K19.52K1.01M320.17K157.01K524.79K3.27M243K78K88.7K22K46K
Interest Expense00000419.28K199K-147.25K-471.04K343.23K0194.53K192.01K128.19K14K16K16K-22K23K
Other Income/Expense979.25K-780K1.06M-1.82M483K74.46M-24.58M941.8K1.33M52.46M1.01M-13.76M36K62.43M-18.23M1.85M-19.35M51.42M-17.17M-596.89K
Pretax Income-6.93M-8.15M-7.86M-15.63M-10.68M-8.01M-12.42M-6.9M-6.54M-11.78M-5.55M-7.32M-6.81M-12.62M-6.85M-5.86M-10.23M-12.89M-7.53M-6.93M
Pretax Margin %-131.68%-136.34%-148.53%-706.97%-407.59%-150.39%-324.4%-309%-454.83%-442.61%-320.95%-456.93%-366.18%-741.53%-243.88%-292.05%-600%-1021.24%-234.29%-265.93%
Income Tax24.65K26K121K64K41K-342.17K239.36K19K40K-303.42K18K35K48K278.91K46.96K15.86K38.76K-39.2K65.87K56.52K
Effective Tax Rate %-0.36%-0.32%-1.54%-0.41%-0.38%4.27%-1.93%-0.28%-0.61%2.58%-0.32%-0.48%-0.7%-2.21%-0.69%-0.27%-0.38%0.3%-0.87%-0.82%
Net Income-6.96M-8.18M-7.98M-15.7M-10.72M-7.67M-12.66M-6.92M-6.58M-11.48M-5.56M-7.36M-6.86M-12.9M-6.9M-5.88M-10.27M-12.85M-7.6M-6.98M
Net Margin %-132.15%-136.77%-150.82%-709.86%-409.16%-143.97%-330.65%-309.85%-457.61%-431.21%-321.99%-459.11%-368.76%-757.92%-245.55%-292.84%-602.27%-1018.14%-236.34%-268.1%
Net Income Growth %35.14%-6.6%37.01%-126.89%-62.86%33.19%-127.59%5.95%4%11.02%19.38%-25.1%33.21%-0.39%9.14%15.81%-8.97%-34.16%-24.34%-31.69%
Net Income (Continuing)-6.96M-8.18M-7.98M-15.7M-10.72M-7.67M-12.66M-6.92M-6.58M-11.48M-5.56M-7.36M-6.86M-12.9M-6.9M-5.88M-10.27M-12.85M-7.6M-6.98M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.19-0.27-0.27-0.52-0.36-0.21-0.38-0.28-0.26-0.42-0.26-0.35-0.32-0.46-0.24-0.29-0.40-0.49-0.29-0.35
EPS Growth %47.22%-28.57%28.95%-85.71%-38.46%50%-46.15%20%18.75%8.7%-8.33%-20.69%20%6.12%17.24%17.14%-8.11%-36.11%9.38%-6.06%
EPS (Basic)-0.19-0.27-0.27-0.52-0.36-0.21-0.38-0.28-0.26-0.42-0.26-0.35-0.32-0.46-0.24-0.29-0.40-0.49-0.29-0.35
Diluted Shares Outstanding36.3M30.73M30.1M30.05M30.04M25.77M24.64M24.44M23.84M21.37M21.4M21.17M20.92M20.86M20.86M20.79M20.78M20.78M20.41M20.35M
Basic Shares Outstanding36.3M30.73M30.1M30.05M30.04M25.77M24.64M24.44M23.84M21.37M21.28M21.17M20.92M20.71M20.82M20.79M20.78M20.78M20.41M20.35M
Dividend Payout Ratio--------------------